SCHEMBL29435634

SCHEMBL29435634

CN1CC=C(c2ccnc(C#N)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ QDPR P09417 3/20 0.50
▸ GABRA5 P31644 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22583246 1.00 QDPR (0.50) QDPRGABRA5SLC6A4
SCHEMBL14865163 0.80 QDPR (0.55) QDPRGABRA5
SCHEMBL8172220 0.75 QDPR (0.62) QDPR
SCHEMBL22583321 0.74 QDPR (0.52) QDPRGABRA5
Hydrochloric Acid SCHEMBL22583432 0.73 QDPR (0.51) QDPRGABRA5
SCHEMBL9792895 0.71 MYC (0.62) —
SCHEMBL31133396 0.71 MYC (0.62) —
SCHEMBL21038276 0.70 CHRNB2 (0.49) QDPRSLC6A4
SCHEMBL12892644 0.70 QDPR (0.60) QDPR
Hydrochloric Acid SCHEMBL19717522 0.69 QDPR (0.62) QDPRSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3959207-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2022-03-02 — — EP disclosed
Send feedback